The effects of interferon (IFN)-α, IFN-β and IFN-γ on human papillomavirus (HPV) oncogene expression were studied in various cervical carcinoma cell lines containing integrated copies of either HPV type 16 or HPV type 18. The levels of E6 and E7 transcripts were examined 6 h and 30 h after treatment with IFN. In HeLa cells, all three classes of IFNs effected a decrease in the level of HPV-18 E6 and E7 transcripts. On the other hand, none of the IFNs altered the level of these transcripts in C-4II cells. Only IFN-γ decreased the level of HPV-16 E6 and E7 transcripts in CaSki and HPK1A cells, while IFN-γ actually increased the level of these transcripts in SiHa cells. This differential IFN regulation of HPV expression in various cervical cancer cell lines may account for the contradictory clinical results observed after treatment of cervical cancer with IFN.


Article metrics loading...

Loading full text...

Full text loading...



  1. Agarwal, C., Hembree, J. R., Rorke, E. A. & Eckert, R. L. (1994). Interferon and retinoic acid suppress the growth of human papillomavirus type 16 immortalized cervical epithelial cells, but only interferon suppresses the level of the human papillomavirus transforming oncogenes. Cancer Research 54, 2108-2112. [Google Scholar]
  2. Arany, I., Nagamani, K. & Tyring, S. K. (1995). Interferon resistance is independent from copy numbers in benign HPV-induced lesions.Anticancer Research 15, 1003-1006. [Google Scholar]
  3. Baker, C. C., Phelps, W. C., Lindgren, V., Braun, M. J., Gonda, M. A. & Howley, P. M. (1987). Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. Journal of Virology 61, 962-971. [Google Scholar]
  4. Bornstein, J., Ben-David, Y., Atad, J., Pascal, B., Revel, M. & Abramovici, H. (1993). Treatment of cervical intraepithelial neoplasia and invasive squamous cell carcinoma by interferon. Obstetrical and Gynecological Survey 48, 251-260.[CrossRef] [Google Scholar]
  5. Bosch, F. X., Manos, M. M., Munoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R. & Shah, K. V. (1995). Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. Journal of the National Cancer Institute 87, 796-802.[CrossRef] [Google Scholar]
  6. Byrne, M. A., Moller, B. R., Taylor-Robinson, D., Harris, J. R., Wickenden, C., Malcolm, A. D., Anderson, M. C. & Coleman, D. V. (1986). The effect of interferon on human papillomaviruses associated with cervical intraepithelial neoplasia. British Journal of Obstetrics and Gynaecology 93, 1136-1144.[CrossRef] [Google Scholar]
  7. Choo, Y. C., Seto, W. H., Hsu, C., Merigan, T. C., Tan, Y. H., Ma, H. K. & Ng, M. H. (1986). Cervical intraepithelial neoplasia treated by perilesional injection of interferon. British Journal of Obstetrics and Gynaecology 93, 372-379. [Google Scholar]
  8. De Marco, F. & Marcante, M. L. (1993). HPV-16 E6–E7 differential transcription induced in SiHa cervical cancer cell line by interferons. Journal of Biological Regulators and Homeostatic Agents 7, 15-21. [Google Scholar]
  9. De Palo, G., Stefanon, B., Rilke, F., Pilotti, S. & Ghione, M. (1985). Activity of human fibroblast interferon by intra-perilesional injections on cervical intraepithelial neoplasia associated with papilloma virus infection. Serono Symposia Publications 24, 297-302. [Google Scholar]
  10. Durst, M., Dzarlieva-Petrusevska, R. T., Boukamp, P., Fusenig, N. E. & Gissman, L. (1987). Molecular and cytogenetic analysis of immortalized primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene 1, 251-256. [Google Scholar]
  11. Durst, M., Seagon, S., Wanschura, S., zur Hausen, H. & Bullerdiek, J. (1995). Malignant progression of an HPV16-immortalized human keratinocyte cell line (HPKIA) in vitro.Cancer Genetics and Cytogenetics 85, 105-112.[CrossRef] [Google Scholar]
  12. Frost, L., Skajaa, K., Hvidman, L. E., Fay, S. J. & Larsen, P. M. (1990). No effect of intralesional injection of interferon on moderate cervical intraepithelial neoplasia. British Journal of Obstetrics and Gynaecology 97, 626-630.[CrossRef] [Google Scholar]
  13. Garcia-Milian, R., Rios, M. A., Amigo, M., Diaz, D., Guilar, O., Siveira, M., Arana, M. J. & Perea, S. E. (1996). Modulation of human papillomavirus type 16 mRNA in cervical invasive carcinoma patients by interferon-alpha therapy. Journal of Interferon and Cytokine Research 16, 739-743.[CrossRef] [Google Scholar]
  14. Gross, G. (1997). Therapy of human papillomavirus infection and associated epithelial tumors. Intervirology 40, 368-377.[CrossRef] [Google Scholar]
  15. Hudson, J. B., Bedell, M. A., McCance, D. J. & Laimins, L. A. (1990). Immortalization and altered differentiation of human keratinocytes in vitro by the E6 and E7 open reading frames of human papillomavirus type 18. Journal of Virology 64, 519-526. [Google Scholar]
  16. Hunter, T. (1991). Cooperation between oncogenes.Cell 64, 249-270.[CrossRef] [Google Scholar]
  17. Krusic, J., Kirhmajer, V., Knezevic, M., Ikic, D., Maricic, Z., Rode, B., Jusic, D. & Soos, E. (1981). Influence of human leukocyte interferon on squamous cell carcinoma of uterine cervix: clinical, histological, and histochemical observations. Journal of Cancer Research and Clinical Oncology 101, 309-315.[CrossRef] [Google Scholar]
  18. Lazo, P. D. (1987). Structure, DNaseI hypersensitivity and expression of integrated papilloma virus in the genome of HeLa cells. European Journal of Biochemistry 165, 393-401.[CrossRef] [Google Scholar]
  19. Lippman, S. M., Kavanagh, J. J., Paredes-Espinoza, M., Delgadillo-Madrueno, F., Paredes-Casillas, P., Hong, W. K., Holdener, E. & Krakoff, I. H. (1992). 13-cis-retinoic acid plus interferon α-2a: highly active systemic therapy for squamous cell carcinoma of the cervix. Journal of the National Cancer Institute 84, 241-245.[CrossRef] [Google Scholar]
  20. Moller, B. R., Johannesen, P., Osther, K., Ulmsteen, U., Hastrup, J. & Berg, K. (1983). Treatment of dysplasia of the cervical epithelium with an interferon gel. Obstetrics and Gynecology 62, 625-629. [Google Scholar]
  21. Munger, K., Phelps, W. C., Bubb, V., Howley, P. M. & Schlegel, R. (1989). The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. Journal of Virology 63, 4417-4421. [Google Scholar]
  22. Nawa, A., Nishiyama, Y., Yamamoto, N., Maeno, K., Goto, S. & Tomoda, Y. (1990). Selective suppression of human papilloma virus type 18 mRNA level in HeLa cells by interferon.Biochemical and Biophysical Research Communications 170, 793-799.[CrossRef] [Google Scholar]
  23. Rotola, A., Costa, S., Di Luca, D., Stefanon, B., Villani, C., Micheletti, L., Montemagno, U., Bolis, P. F. & Cassai, E. (1995). β-Interferon treatment of cervical intraepithelial neoplasia: a multicenter clinical trial.Intervirology 38, 325-331. [Google Scholar]
  24. Schneider, A., Grubert, T., Kirchmayr, R., Wagner, D., Papendick, U. & Schlunck, G. (1995). Efficacy trial of topically administered interferon gamma-1β gel in comparison to laser treatment in cervical intraepithelial neoplasia. Archives of Gynecology and Obstetrics 256, 75-83.[CrossRef] [Google Scholar]
  25. Toma, S., Ragni, N., Raffo, P., Boselli, F., Gustavino, C., Rugiati, S., Formelli, F., Palumbo, R., Rosso, R. & De Cecco, L. (1996). Efficacy of the association of 13-cis-retinoic acid (13cRA) and alpha-interferon 2a (α-IFN 2a) in moderate-severe cervical intraepithelial neoplasia (CIN II-III): a pilot study. Anticancer Research 16, 931-936. [Google Scholar]
  26. Vasilyev, R. V., Bokhman, J. V., Smorodintsev, A. A., Chepik, O. F., Novik, V. I., Garmanova, N. V., Stepanov, A. N. & Iovlev, V. I. (1990). An experience with application of human leucocyte interferon for cervical cancer treatment. European Journal of Gynaecological Oncology 11, 313-317. [Google Scholar]
  27. Wadler, S., Burk, R. D., Neuberg, D., Rameau, R., Runowicz, C. D., Goldberg, G., McGill, F., Tachezy, R., Comis, R., Edmonson, J. & Wiernik, P. H. (1995). Lack of efficacy of interferon-α therapy in recurrent, advanced cervical cancer.Journal of Interferon and Cytokine Research 15, 1011-1016. [Google Scholar]
  28. Woodworth, C. D., Lichti, U., Simpson, S., Evans, C. H. & DiPaolo, J. A. (1992). Leukoregulin and γ-interferon inhibit human papillomavirus type 16 gene transcription in human papillomavirus-immortalized human cervical cells. Cancer Research 52, 456-463. [Google Scholar]

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error